이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
규제 및 법률 · 2015. 9. 29.1 분 읽기
Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events
로컬 자동 번역 · 원본 출처 언어
요약
The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) will be providing a Single Source Competition Supplement to Harvard Pilgrim Healthcare, an awardee of the Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events Cooperative Agreement. The single source supplement will fund research utilizing proprietary methods to improve sepsis prevention by better defining the burden, preventability and identifying measurers to track progress.
원본 출처 언어: Federal Register — All Documents원문 발표 열기 →